Intracerebral hemorrhage

Last updated: July 25, 2022

Summarytoggle arrow icon

Intracerebral hemorrhage (ICH) refers to bleeding within the brain parenchyma. The term should not be confused with intracranial hemorrhage, which is a broader term that encompasses bleeding within any part of the skull, i.e., extradural, subdural, subarachnoid, or intracerebral bleeding. The most significant risk factor for spontaneous ICH is arterial hypertension. Symptoms are often nonspecific (e.g., headache); however, depending on the affected vessel and cerebral region, focal neurological deficits (e.g., hemiparesis) may occur. Compared with ischemic stroke, patients with ICH are more likely to present with severe headache and have rapidly progressing symptoms. The initial imaging investigation of choice is CT head without contrast, which typically shows a hyperdense mass lesion. Treatment involves management of the underlying and associated conditions (e.g., controlling hypertension, reversing coagulopathy) in order to limit hematoma expansion and prevent secondary brain injury. In severe cases, neurosurgical intervention may be required. Approximately half of patients with spontaneous ICH die within 30 days of symptom onset. Traumatic ICH may result from traumatic brain injury (TBI) and is managed similarly to spontaneous ICH.

See also “Overview of intracranial hemorrhage” and “Overview of stroke” for more information.

  • ICH is responsible for approx. 10% of all strokes. [1]
  • Most commonly affects the deep structures of the brain [2]
  • Intraventricular extension occurs in approx. 30% of patients with ICH.

Epidemiological data refers to the US, unless otherwise specified.

References:[3][4][5]

For the approach to patients with suspected traumatic ICH, see “Management of traumatic ICH.”

Initial evaluation [7][8][9]

Consider the sudden onset of focal neurological deficits a vascular event until proven otherwise and evaluate patients as promptly as possible (preferably within the so-called “golden hour”). [10][11][12]

Patients with signs of brain herniation should be evaluated immediately for neurosurgical intervention!

Monitoring

Acute stabilization should begin immediately after symptom onset, in parallel with diagnostic measures, with the goal of reducing hematoma expansion and limiting secondary brain injury. [7]

Remember to stop all anticoagulants and antiplatelet medication, including aspirin, in patients with ICH.

Platelet transfusion is not routinely indicated in patients with normal platelet counts taking antiplatelet agents (e.g., aspirin, clopidogrel). [7][20][21]

Approach to ICH diagnostics [7][9][13]
Time interval from initial presentation Laboratory studies Imaging
Within the first hour
  • CT head without contrast
  • MRI head (alternative)
Hours to days

Characteristic neuroimaging findings [24]

Variation in ICH density on imaging over time [25][26]
Time since ICH Hematoma density

CT without contrast

MRI (T2 weighted)
Hyperacute (< 24 hours)

Hyperdense

Hyperintense

Acute (1–3 days)

Hyperdense with fluid level and hypodense perifocal edema

Hypointense with a hyperintense border

Early subacute (> 3 days to 1 week)

Hyperdense becoming isodense

Hypointense

Late subacute (weeks to months)

Isodense or hypodense

Hyperintense

Chronic (> months)

Hypodense

Hypointense

  • Additional possible features
    • Midline shift and/or mass effect; (if significant, this should raise suspicion for impending herniation)
    • Intraventricular extension [9]

Angiography findings

Angiography may be performed to assess for signs of further bleeding and structural abnormalities in patients with suspected underlying pathology (e.g., patients aged < 55 years and those without risk factors for ICH). [7]

  • CTA spot sign [27]
    • Definition: localized area of enhancement visible within an intracerebral hemorrhage only after administration of IV contrast
    • Implication: indicates active hemorrhage; is a predictor of hematoma expansion [7][27][28]
  • Aneurysms or other vascular lesions

Approach

Detection and management of complications

Common complications following spontaneous ICH [7]
Complication Screening and management
Dysphagia [29]

Seizures

Cardiac abnormalities
Electrolyte abnormalities

Venous thromboembolism (VTE)

Hematoma expansion
  • Perform regular neurological examinations.
  • Consider: [35]
    • Early CTA (within 3 hours of assessment) to assess for hematoma expansion [26]
    • CT without contrast 24 hours after presentation to determine the final size of the hematoma
    • Transcranial duplex ultrasonography

Prophylactic anticonvulsants are not recommended in patients with ICH. [7]

Surgical management [7]

Neurosurgical consultation is advised for acute ICP management (see “Acute stabilization”) and definitive management. Evacuation of the hematoma may be appropriate depending on the size, location, and associated clinical features of the ICH.

Hematoma evacuation

Decompressive craniotomy

The management of traumatic ICH is similar to the management of spontaneous ICH, with some modifications.

See “Differential diagnoses of stroke.”

The differential diagnoses listed here are not exhaustive.

We list the most important complications. The selection is not exhaustive.

  • 30-day mortality ranges from 25% to 50%. [41][42]
  • Patients aged > 65 years and those with large hematomas and low GCS scores (≤ 11) typically have poor outcomes. [41][42]
  • The ICH score is used to assess the severity of bleeds, and, in conjunction with other features, to estimate the patient's prognosis. [7]
ICH score [43][44]
Variable Findings Points
GCS score 3–4 2
5–12 1
13–15 0
ICH volume ≥ 30 cm3 1
< 30 cm3 0
Intraventricular hematoma Yes 1
No 0
ICH of infratentorial origin Yes 1
No 0
Patient age ≥ 80 years 1
< 80 years 0

Total ICH score: 0–6

Predicted 30-day mortality

  • Score = 0: 0%
  • Score = 1: 13%
  • Score = 2: 26%
  • Score = 3: 72%
  • Score = 4: 97%
  • Score = 5: 100%
  • Score = 6: estimated to be 100%

The ICH score was designed to assess ICH severity and aid clinical communication; it should not be used in isolation to determine prognosis!

  1. Kasper DL, Fauci AS, Hauser S, Longo D, Jameson LJ, Loscalzo J . Harrisons Principles of Internal Medicine . McGraw-Hill Medical Publishing Division ; 2016
  2. Berlit P. Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord. 2010; 3 (1): p.29–42.
  3. Chen M. Stroke as a Complication of Medical Disease. Semin Neurol. 2009; 29 (2): p.154-162. doi: 10.1055/s-0029-1213735 . | Open in Read by QxMD
  4. Daroff RB, et al.. Bradley's Neurology in Clinical Practice. Elsevier
  5. Delcourt et al.. Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology. 2017; 88 (15): p.1408–1414. doi: 10.1212/WNL.0000000000003771 . | Open in Read by QxMD
  6. Hemphill JC, Greenberg SM, Anderson CS et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke. 2015; 46 (7). doi: 10.1161/STR.0000000000000069 . | Open in Read by QxMD
  7. Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012; 11 (1): p.101-118. doi: 10.1016/S1474-4422(11)70264-2 . | Open in Read by QxMD
  8. Walls R, Hockberger R, Gausche-Hill M. Rosen's Emergency Medicine. Elsevier Health Sciences ; 2018
  9. Carney N, Totten AM, O’Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2016; 80 (1): p.6-15. doi: 10.1227/neu.0000000000001432 . | Open in Read by QxMD
  10. American College of Surgeons and the Committee on Trauma. ATLS Advanced Trauma Life Support. American College of Surgeons ; 2018
  11. Kvint S, Gutierrez A, Blue R, Petrov D. Surgical Management of Trauma-Related Intracranial Hemorrhage—a Review. Curr Neurol Neurosci Rep. 2020; 20 (12). doi: 10.1007/s11910-020-01080-0 . | Open in Read by QxMD
  12. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
  13. Joundi RA, Martino R, Saposnik G, Giannakeas V, Fang J, Kapral MK. Dysphagia screening after intracerebral hemorrhage. International Journal of Stroke. 2017; 13 (5): p.503-510. doi: 10.1177/1747493017729265 . | Open in Read by QxMD
  14. Junttila E, Vaara M, Koskenkari J, et al. Repolarization abnormalities in patients with subarachnoid and intracerebral hemorrhage: predisposing factors and association with outcome.. Anesth Analg. 2013; 116 (1): p.190-7. doi: 10.1213/ANE.0b013e318270034a . | Open in Read by QxMD
  15. Hasegawa K, Fix ML, Wendell L, et al. Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage.. Am J Emerg Med. 2012; 30 (4): p.545-52. doi: 10.1016/j.ajem.2011.02.007 . | Open in Read by QxMD
  16. Sandhu R, Aronow WS, Rajdev A, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage.. Am J Cardiol. 2008; 102 (5): p.632-4. doi: 10.1016/j.amjcard.2008.04.036 . | Open in Read by QxMD
  17. Koivunen R-J, Haapaniemi E, Satopää J, Niemelä M, Tatlisumak T, Putaala J. Medical Acute Complications of Intracerebral Hemorrhage in Young Adults. Stroke Res Treat. 2015; 2015 : p.1-7. doi: 10.1155/2015/357696 . | Open in Read by QxMD
  18. Farr S, Toor H, Patchana T, et al. Risks, Benefits, and the Optimal Time to Resume Deep Vein Thrombosis Prophylaxis in Patients with Intracranial Hemorrhage. Cureus. 2019 . doi: 10.7759/cureus.5827 . | Open in Read by QxMD
  19. Ovesen C, Havsteen I, Rosenbaum S, Christensen H. Prediction and Observation of Post-Admission Hematoma Expansion in Patients with Intracerebral Hemorrhage. Front Neurol. 2014; 5 . doi: 10.3389/fneur.2014.00186 . | Open in Read by QxMD
  20. Macellari F, Paciaroni M, Agnelli G, Caso V. Neuroimaging in intracerebral hemorrhage.. Stroke. 2014; 45 (3): p.903-8. doi: 10.1161/STROKEAHA.113.003701 . | Open in Read by QxMD
  21. De Oliveira Manoel AL. Surgery for spontaneous intracerebral hemorrhage. Crit Care. 2020; 24 (1). doi: 10.1186/s13054-020-2749-2 . | Open in Read by QxMD
  22. Gregson BA, Mitchell P, Mendelow AD. Surgical Decision Making in Brain Hemorrhage.. Stroke. 2019; 50 (5): p.1108-1115. doi: 10.1161/STROKEAHA.118.022694 . | Open in Read by QxMD
  23. Fogelholm R, Murros K, Rissanen A, Avikainen S. Long term survival after primary intracerebral haemorrhage: a retrospective population based study.. J Neurol Neurosurg Psychiatry. 2005; 76 (11): p.1534-8. doi: 10.1136/jnnp.2004.055145 . | Open in Read by QxMD
  24. Safatli D, Günther A, Schlattmann P, Schwarz F, Kalff R, Ewald C. Predictors of 30-day mortality in patients with spontaneous primary intracerebral hemorrhage. Surg Neurol Int. 2016; 7 (19): p.510. doi: 10.4103/2152-7806.187493 . | Open in Read by QxMD
  25. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.. Stroke. 2001; 32 (4): p.891-7. doi: 10.1161/01.str.32.4.891 . | Open in Read by QxMD
  26. Greenberg MS. Handbook of Neurosurgery. Thieme Medical Publishers ; 2020
  27. Claude Hemphill J, Lam A. Emergency Neurological Life Support: Intracerebral Hemorrhage. Neurocrit Care. 2017; 27 (S1): p.89-101. doi: 10.1007/s12028-017-0453-0 . | Open in Read by QxMD
  28. E. Brooke Lerner, Ronald M. Moscati. The Golden Hour: Scientific Fact or Medical "Urban Legend"?. Academic Emergency Medicine. 2001; 8 (7): p.758-760. doi: 10.1111/j.1553-2712.2001.tb00201.x . | Open in Read by QxMD
  29. Rogers FB, Rittenhouse KJ, Gross BW. The golden hour in trauma: Dogma or medical folklore?. Injury. 2015; 46 (4): p.525-527. doi: 10.1016/j.injury.2014.08.043 . | Open in Read by QxMD
  30. De Oliveira Manoel AL, Goffi A, Zampieri FG, et al. The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care. 2016; 20 (1). doi: 10.1186/s13054-016-1432-0 . | Open in Read by QxMD
  31. Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage.. Neurology. 2006; 66 (9): p.1330-4. doi: 10.1212/01.wnl.0000210523.22944.9b . | Open in Read by QxMD
  32. Mu J, Ni C, Wu M, et al. A Retrospective Study on Risk Factors for Urinary Tract Infection in Patients with Intracranial Cerebral Hemorrhage. BioMed Research International. 2020; 2020 : p.1-7. doi: 10.1155/2020/1396705 . | Open in Read by QxMD
  33. Morotti A, Goldstein JN. Diagnosis and Management of Acute Intracerebral Hemorrhage.. Emerg Med Clin North Am. 2016; 34 (4): p.883-899. doi: 10.1016/j.emc.2016.06.010 . | Open in Read by QxMD
  34. Aguilar MI, Brott TG. Update in intracerebral hemorrhage.. The Neurohospitalist. 2011; 1 (3): p.148-59. doi: 10.1177/1941875211409050 . | Open in Read by QxMD
  35. Wada R, Aviv RI, Fox AJ, et al. CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage. Stroke. 2007; 38 (4): p.1257-1262. doi: 10.1161/01.str.0000259633.59404.f3 . | Open in Read by QxMD
  36. Peng W-J, Reis C, Reis H, Zhang J, Yang J. Predictive Value of CTA Spot Sign on Hematoma Expansion in Intracerebral Hemorrhage Patients. BioMed Research International. 2017; 2017 : p.1-9. doi: 10.1155/2017/4137210 . | Open in Read by QxMD
  37. Rabinstein AA. Optimal Blood Pressure After Intracerebral Hemorrhage. Stroke. 2018; 49 (2): p.275-276. doi: 10.1161/strokeaha.117.020058 . | Open in Read by QxMD
  38. Divani AA, Liu X, Di Napoli M, et al. Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage. Stroke. 2019; 50 (8): p.2023-2029. doi: 10.1161/strokeaha.119.025514 . | Open in Read by QxMD
  39. Boulouis G, Morotti A, Goldstein JN, Charidimou A. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. Journal of Neurology, Neurosurgery & Psychiatry. 2017; 88 (4): p.339-345. doi: 10.1136/jnnp-2016-315346 . | Open in Read by QxMD
  40. Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood Pressure Management After Intracerebral and Subarachnoid Hemorrhage: The Knowns and Known Unknowns. Stroke. 2022; 53 (4): p.1065-1073. doi: 10.1161/strokeaha.121.036139 . | Open in Read by QxMD
  41. Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. BMJ. 2017; 2 (1): p.21-29. doi: 10.1136/svn-2016-000047 . | Open in Read by QxMD
  42. Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care. 2020; 32 (3): p.647-666. doi: 10.1007/s12028-020-00959-7 . | Open in Read by QxMD
  43. Baharoglu MI, Cordonnier C, Salman RA-S, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. The Lancet. 2016; 387 (10038): p.2605-2613. doi: 10.1016/s0140-6736(16)30392-0 . | Open in Read by QxMD
  44. Al-Shahi Salman R, Law ZK, Bath PM, Steiner T, Sprigg N. Haemostatic therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst. Rev.. 2018; 2018 (4). doi: 10.1002/14651858.cd005951.pub4 . | Open in Read by QxMD

3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer